Top Markets
Coin of the day
BIOLASE, Inc. BIOLASE, Inc.

BIOLASE, Inc.

BIOL
Rank in Stocks #42643
BIOLASE, Inc., along with its various divisions, operates as a global... BIOLASE, Inc., along with its various divisions, operates as a global enterprise specializing in the creation, production, distribution, and sale of advanced laser systems. These technologies are specifically designed for dental professionals and their patients across the United States and internationally. The sophisticated laser instruments developed by BIOLASE empower a diverse array of dental specialists—including general dentists, periodontists, endodontists, and oral surgeons—to execute a broad spectrum of minimally invasive procedures. These applications range from cosmetic enhancements and restorative treatments to intricate surgical interventions. Among its core product offerings, the company provides Waterlase all-tissue dental laser systems, which are highly effective for precisely cutting both soft and hard tissues. It also supplies diode soft-tissue laser systems, utilized for procedures involving soft tissue, pain management, teeth whitening, and various other aesthetic treatments. Furthermore, the Epic Hygiene laser assists in addressing non-surgical periodontitis and enhancing overall clinical efficiency. Beyond its primary laser devices, BIOLASE also manufactures and distributes essential consumable items and accessories. This comprehensive range includes flexible fibers, specialized hand pieces, and professional teeth whitening gel kits. The company markets its products through a dedicated in-house sales team and an extensive network of distributors. Established in 1984, the organization was initially known as BIOLASE Technology, Inc., before officially changing its name to BIOLASE, Inc. in 2012. Its corporate headquarters are situated in Foothill Ranch, California.
Share Price
$0.00695
Last synced: 2024-10-29
Market Cap
$536.40
Change (1 day)
-0.71%
Change (1 year)
0.00%
Country
US
Trade BIOLASE, Inc. (BIOL)

Category

Operating Margin for BIOLASE, Inc. (BIOL)
Operating Margin as of August 2026 TTM: -36.48%
According to BIOLASE, Inc. latest financial reports and stock price the company's current Operating Margin (TTM) is -36.48%. At the end of 2022 the company had an Operating Margin of -52.28%.
Operating Margin history for BIOLASE, Inc. from 2000 to 2026
Operating Margin at the end of each year
Year Operating Margin Change
2026 (TTM) -36.48% 0.00%
2023 -36.48% -30.22%
2022 -52.28% 27.14%
2021 -41.12% -49.47%
2020 -81.37% 96.88%
2019 -41.33% -8.66%
2018 -45.25% 17.72%
2017 -38.44% 33.10%
2016 -28.88% -29.70%
2015 -41.08% 9.11%
2014 -37.65% 93.18%
2013 -19.49% 341.95%
2012 -4.41% -46.22%
2011 -8.20% -81.29%
2010 -43.83% 541.73%
2009 -6.83% -49.74%
2008 -13.59% 1.34%
2007 -13.41% 93.23%
2006 -6.94% -74.67%
2005 -27.40% 77.58%
2004 -15.43% -201.78%
2003 15.16% 78.35%
2002 8.50% -518.72%
2001 -2.03% -94.60%
2000 -37.62% 0.00%
Operating Margin for similar companies or competitors
Company Operating Margin Operating Margin Difference Country
17.03% -100.47%
US
22.03% -100.60%
US
17.86% -100.49%
IE
21.46% -100.59%
US
28.09% -100.77%
US
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.